NEW YORK (360Dx) – Erba Diagnostics Mannheim today said that it has acquired the Calbiotech group of companies specializing in immunoassay development and manufacturing.
Financial terms of the deal were not disclosed.
Calbiotech is based in Spring Valley, California and has a range of ELISA and CLIA assays for human and animal research, including assays for autoimmune disorders, cancer, and infectious diseases. It has more than 200 products, distributed to more than 60 countries, Erba said in a statement.
The Calbiotech group includes Calbiotech Veterinary, which manufactures veterinary diagnostics, and Moduline Systems, which manufactures high-precision liquid dispensing systems.
Suresh Vazirani, chairman and managing director of Erba, said that Calbiotech's "expertise in immunoassay and will allow Erba to strengthen our position in this high-growth market and integrate their strong R&D program to further enhance the product development strategy of Erba."
Erba, headquartered in Mannheim, Germany has operations in Europe, the US, Russia, and Asia. Its products include those in clinical chemistry, immunology, hematology, coagulation, critical care, urine analysis, diabetes monitoring, microbiology, and molecular diagnostics, it said.